MYBPHL and Miyoshi myopathy: By bisulfite genomic sequencing (BGS), DNA methylation of the MYBPHL enhancer was studied in bisulfite-converted DNA of CD138-sorted normal plasma cells from healthy bone marrow donors (n = 7), human MM cell lines (HMCLs; n = 7), and an enzymatically methylated positive control DNA.